Whittier Trust’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.66K | Hold |
53
| – | – | ﹤0.01% | 1299 |
|
|
2025
Q1 | $5.86K | Hold |
53
| – | – | ﹤0.01% | 1298 |
|
|
2024
Q4 | $7.23K | Hold |
53
| – | – | ﹤0.01% | 1301 |
|
|
2024
Q3 | $6.11K | Sell |
53
-90
| -63% | -$10.4K | ﹤0.01% | 1350 |
|
|
2024
Q2 | $19.7K | Hold |
143
| – | – | ﹤0.01% | 1094 |
|
|
2024
Q1 | $19.7K | Hold |
143
| – | – | ﹤0.01% | 1136 |
|
|
2023
Q4 | $18.8K | Sell |
143
-3
| -2% | -$395 | ﹤0.01% | 1110 |
|
|
2023
Q3 | $16.4K | Buy |
146
+3
| +2% | +$337 | ﹤0.01% | 1159 |
|
|
2023
Q2 | $13.5K | Hold |
143
| – | – | ﹤0.01% | 1210 |
|
|
2023
Q1 | $14.5K | Hold |
143
| – | – | ﹤0.01% | 1221 |
|
|
2022
Q4 | $17.1K | Hold |
143
| – | – | ﹤0.01% | 1182 |
|
|
2022
Q3 | $15K | Hold |
143
| – | – | ﹤0.01% | 1262 |
|
|
2022
Q2 | $14K | Hold |
143
| – | – | ﹤0.01% | 1254 |
|
|
2022
Q1 | $13K | Sell |
143
-147
| -51% | -$13.4K | ﹤0.01% | 1291 |
|
|
2021
Q4 | $25K | Buy |
290
+147
| +103% | +$12.7K | ﹤0.01% | 1129 |
|
|
2021
Q3 | $14K | Hold |
143
| – | – | ﹤0.01% | 1203 |
|
|
2021
Q2 | $14K | Sell |
143
-117
| -45% | -$11.5K | ﹤0.01% | 1218 |
|
|
2021
Q1 | $25K | Buy |
260
+117
| +82% | +$11.3K | ﹤0.01% | 1087 |
|
|
2020
Q4 | $14K | Buy |
143
+90
| +170% | +$8.81K | ﹤0.01% | 1112 |
|
|
2020
Q3 | $5K | Hold |
53
| – | – | ﹤0.01% | 1234 |
|
|
2020
Q2 | $6K | Hold |
53
| – | – | ﹤0.01% | 1138 |
|
|
2020
Q1 | $5K | Hold |
53
| – | – | ﹤0.01% | 1217 |
|
|
2019
Q4 | $6K | Hold |
53
| – | – | ﹤0.01% | 1217 |
|
|
2019
Q3 | $5K | Buy |
+53
| New | +$5K | ﹤0.01% | 1255 |
|